Efficacy of ustekinumab after failure of infliximab CT-P13 in a HLA-Cw6-positive patient affected by pityriasis rubra pilaris: monitoring with reflectance confocal microscopy (RCM) and optical coherence tomography (OCT)

J Eur Acad Dermatol Venereol. 2017 May;31(5):e249-e251. doi: 10.1111/jdv.14009. Epub 2016 Oct 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Dermatologic Agents / therapeutic use
  • Female
  • HLA-C Antigens / immunology*
  • Humans
  • Infliximab / pharmacology*
  • Microscopy, Confocal / methods*
  • Pityriasis Rubra Pilaris / diagnosis
  • Pityriasis Rubra Pilaris / drug therapy*
  • Pityriasis Rubra Pilaris / immunology
  • Skin / pathology*
  • Tomography, Optical Coherence / methods*
  • Treatment Failure
  • Ustekinumab / therapeutic use*

Substances

  • Dermatologic Agents
  • HLA-C Antigens
  • HLA-C*06 antigen
  • Infliximab
  • Ustekinumab